$52.90
2.13% day before yesterday
NYSE, Sep 12, 10:00 pm CET

Conmed Corp. Stock price

$52.90
-1.11 2.06% 1M
-6.22 10.52% 6M
-15.54 22.71% YTD
-24.02 31.23% 1Y
-46.35 46.70% 3Y
-33.83 39.01% 5Y
+1.64 3.20% 10Y
+23.44 79.57% 20Y
NYSE, Closing price Fri, Sep 12 2025
-1.15 2.13%

Key metrics

Basic
Market capitalization
$1.6b
Enterprise Value
$2.5b
Net debt
$847.9m
Cash
$33.9m
Shares outstanding
31.0m
Valuation (TTM | estimate)
P/E
14.9 | 11.6
P/S
1.2 | 1.2
EV/Sales
1.9 | 1.8
EV/FCF
16.8
P/B
1.6
Dividends
DPS
$0.80
Yield 1Y | 5Y
1.5% | 0.8%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
18.8% | 66.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$225.7m | $290.8m
EBIT
$190.8m | $213.9m
Net Income
$110.2m | $141.1m
Free Cash Flow
$148.2m
Growth (TTM | estimate)
Revenue
3.9% | 6.7%
EBITDA
10.0% | 19.2%
EBIT
12.0% | 2.2%
Net Income
11.8% | 6.6%
Free Cash Flow
-6.8%
Margin (TTM | estimate)
Gross
56.1%
EBITDA
17.0% | 20.8%
EBIT
14.4%
Net
8.3% | 10.1%
Free Cash Flow
11.2%
Financial Health
Equity Ratio
41.7%
Return on Equity
13.8%
ROCE
9.4%
ROIC
7.4%
Debt/Equity
0.9
More
EPS
$3.5
FCF per Share
$4.8
Short interest
9.2%
Employees
4k
Rev per Employee
$340.0k
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

Buy
50%
Hold
50%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,326 1,326
4% 4%
100%
- Direct Costs 583 583
2% 2%
44%
743 743
5% 5%
56%
- Selling and Administrative Expenses 482 482
6% 6%
36%
- Research and Development Expense 54 54
1% 1%
4%
226 226
10% 10%
17%
- Depreciation and Amortization 35 35
0% 0%
3%
EBIT (Operating Income) EBIT 191 191
12% 12%
14%
Net Profit 110 110
12% 12%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
5 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025. “My fellow directors and I are delighted to welcome Kim to the board,” said LaVerne Council, Chair of CONMED's Board of Directors. “Kim brings extensive global leadership experience across life sciences businesses, with a strong tra...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3, 2025, to all shareholders of record as of September 15, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Compa...
Positive
The Motley Fool
about 2 months ago
Conmed (CNMD) Q2 EPS Jumps 17%
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today